Distalmotion today announced the first successful U.S. outpatient procedures with its Dexter surgical robot platform.

Less than 30 days after receiving FDA De Novo marketing authorization, Distalmotion's Dexter Surgical Robot has successfully ...

Swiss robotics company Distalmotion has seen its Dexter surgical robot, designed for adult inguinal hernia repair, granted De ...

Distalmotion has grabbed hold of a de novo clearance for its Dexter surgical robot, a system designed for hospitals as well as ambulatory surgery centers. The robotic assistant was cleared by the ...

Over 90% of hernia repairs are currently performed in the ASC setting, and the new robot is specifically tailored for those environments. The robot's design and form factor are both small, making it ...

Distalmotion’s Dexter Surgical Robot opens an entirely new era for soft tissue robotics in the outpatient setting and ambulatory surgery centers that will have immediate benefit for patients.

Distalmotion has been granted De Novo approval by the U.S. Food and Drug Administration (FDA) to market the Dexter Surgical ...

Distalmotion's mission is to empower robotic surgery excellence by expanding access and improving care with robotic assisted surgery in the hospital outpatient and ambulatory surgery centers (ASC's) ...